about
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentATP5H/KCTD2 locus is associated with Alzheimer's disease risk.Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.Normative data of a brief neuropsychological battery for Spanish individuals older than 49Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility geneCut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease.Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer's disease.Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment.Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic.Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer’s Disease.Association of TMEM106B rs1990622 marker and frontotemporal dementia: evidence for a recessive effect and meta-analysis.A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates.Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old.Impact of Recruitment Methods in Subjective Cognitive Decline.The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.Genome-wide significant risk factors on chromosome 19 and the APOE locus.Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's diseaseExploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive EndophenotypesMolecular evaluation of human Ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients
P50
Q33629452-36718F50-14C2-457C-8ED8-53F17EA0DC4FQ33652534-5D33BC64-9A0C-4D28-B36A-5B2CCA70371CQ33837891-A50FC8F7-B06B-4082-87E8-EDBF1690A3D8Q33953312-ABED0A7C-9204-459C-9371-7CB730FB8617Q34093550-DFFB57CA-7370-46B4-BC5D-548792CC0F40Q34402261-B40DDA5B-D12C-44E9-9667-22583FDB850EQ35022765-51BAB915-71F7-4F45-B31F-CF13A96A4CDEQ35060510-95E6F5F0-2A3D-4009-B1DA-9D562E4F93A2Q35558526-D104CF2E-38ED-4C87-9101-A2775C9BE0F4Q35837451-695A8E7E-F012-43D3-B360-0216A31A61F8Q36142354-235DD34B-E77D-429A-9B86-A6FDDBB92AD2Q36573598-5AA5DEC1-9C54-42D5-9D00-020EFCCFBF2BQ36660799-7AC80FBC-2206-469F-9184-BCE73D9959F6Q37347911-CB88445E-6B42-4297-8D5E-BBA0F821A0F5Q37721132-C7B6C476-70BC-48D7-A524-E9F0E1051B0FQ38605663-88272116-263E-4E42-8F52-CF2CAE4C3E5AQ39963955-79B47C30-A477-46A1-9580-C79D719E6AAEQ40457852-59DD7891-D1B1-497E-B5BB-34EE84FA639DQ41103306-9C889B2B-CFBB-4FE3-A69F-339CE8418936Q41542106-624BA5B6-55B4-48F9-B65A-329150A3BA2EQ45013520-DD55BF34-9616-4FB9-80EC-B78677FA806BQ46103376-FE40D979-7CE6-40E3-8156-AD187279CB12Q46156158-D543A834-6DB1-4A41-A562-D17C87288337Q46752582-6811D1DC-D17A-4AAB-9CAA-C5347DE3F142Q47952621-5ABEDAD5-3769-4BCB-8A9D-561F1BD77A2FQ50533660-7C1C40EE-3BFB-4DAD-B8FC-0D7907EB8CABQ50534625-ABBCD990-0CF9-41DD-9378-A155DD1C5F27Q53389711-67069CD6-9D4D-4BB7-8495-822722D1EE84Q54995495-F820E959-EAF1-4969-A963-3EBD0B6D45D5Q58612352-35A2FF31-7F1F-4D2B-A64B-B833FEE0A925Q58693792-9726F248-7734-4BE4-9A64-08607CD697C1Q59543775-13A13C52-61ED-44A4-99F5-878DCA151D29
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Ana Espinosa
@ast
Ana Espinosa
@en
Ana Espinosa
@es
Ana Espinosa
@nl
Ana Espinosa
@sl
type
label
Ana Espinosa
@ast
Ana Espinosa
@en
Ana Espinosa
@es
Ana Espinosa
@nl
Ana Espinosa
@sl
altLabel
A Espinosa
@en
prefLabel
Ana Espinosa
@ast
Ana Espinosa
@en
Ana Espinosa
@es
Ana Espinosa
@nl
Ana Espinosa
@sl
P106
P21
P31
P496
0000-0001-8414-6522